Orient Pharma Co Stock Current Valuation
| 4166 Stock | TWD 37.95 0.35 0.93% |
Valuation analysis of Orient Pharma helps investors to measure Orient Pharma's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Orient Pharma's price fluctuation is not too volatile at this time. Calculation of the real value of Orient Pharma is based on 3 months time horizon. Increasing Orient Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Orient stock is determined by what a typical buyer is willing to pay for full or partial control of Orient Pharma Co. Since Orient Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Orient Stock. However, Orient Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 37.95 | Real 30.85 | Hype 37.95 | Naive 37.57 |
The intrinsic value of Orient Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Orient Pharma's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Orient Pharma Co helps investors to forecast how Orient stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Orient Pharma more accurately as focusing exclusively on Orient Pharma's fundamentals will not take into account other important factors: Orient Pharma Co Company Current Valuation Analysis
Orient Pharma's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Orient Pharma Current Valuation | 3.23 B |
Most of Orient Pharma's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Orient Pharma Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Orient Pharma Co has a Current Valuation of 3.23 B. This is 77.51% lower than that of the Healthcare sector and 98.22% lower than that of the Drug Manufacturers - Major industry. The current valuation for all Taiwan stocks is 80.57% higher than that of the company.
Orient Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Orient Pharma's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Orient Pharma could also be used in its relative valuation, which is a method of valuing Orient Pharma by comparing valuation metrics of similar companies.Orient Pharma is currently under evaluation in current valuation category among its peers.
Orient Fundamentals
| Return On Equity | -14.97 | |||
| Return On Asset | -8.89 | |||
| Profit Margin | (61.79) % | |||
| Operating Margin | (79.63) % | |||
| Current Valuation | 3.23 B | |||
| Shares Outstanding | 156.01 M | |||
| Price To Book | 2.74 X | |||
| Price To Sales | 10.53 X | |||
| Revenue | 285.29 M | |||
| Gross Profit | 5.66 M | |||
| EBITDA | (166.81 M) | |||
| Net Income | (176.29 M) | |||
| Cash And Equivalents | 64.58 M | |||
| Cash Per Share | 0.41 X | |||
| Total Debt | 287.34 M | |||
| Debt To Equity | 26.20 % | |||
| Current Ratio | 1.18 X | |||
| Book Value Per Share | 7.03 X | |||
| Cash Flow From Operations | (192.55 M) | |||
| Earnings Per Share | (1.13) X | |||
| Number Of Employees | 13 | |||
| Beta | 0.62 | |||
| Market Capitalization | 3 B | |||
| Z Score | 6.0 |
About Orient Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Orient Pharma Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Orient Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Orient Pharma Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Orient Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Orient Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orient Pharma will appreciate offsetting losses from the drop in the long position's value.Moving together with Orient Stock
Moving against Orient Stock
| 0.88 | 4102 | Yung Zip Chemical | PairCorr |
| 0.76 | 4108 | Phytohealth Corp | PairCorr |
| 0.35 | 0051 | YuantaP shares Taiwan | PairCorr |
The ability to find closely correlated positions to Orient Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Orient Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Orient Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Orient Pharma Co to buy it.
The correlation of Orient Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Orient Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Orient Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Orient Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Orient Stock Analysis
When running Orient Pharma's price analysis, check to measure Orient Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orient Pharma is operating at the current time. Most of Orient Pharma's value examination focuses on studying past and present price action to predict the probability of Orient Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orient Pharma's price. Additionally, you may evaluate how the addition of Orient Pharma to your portfolios can decrease your overall portfolio volatility.